Table 2A. C-indexes for application of EORTC model in the entire cohort of 4689 patients with non-muscle-invasive urothelial carcinoma of the bladder.

		Published EORTC estimates
	Current study	1 Year	5 Years
Disease recurrence	0.597	0.660	0.660
Disease progression	0.662	0.740	0.750

Abbreviation: EORTC=European Organization for Research and Treatment of Cancer.